- €941.31m
- €913.90m
- €19.52m
Teva gains after FDA approves monthly schizophrenia injection
Corrected: UPDATE 1-Teva wins FDA approval for monthly schizophrenia injection Weltruza
Teva wins FDA approval for monthly schizophrenia injection Weltruza
Brief: Medincell Announces Temporary Shares Trading Suspension On Euronext Paris
Brief: Medincell Appoints Edna Venneker, MD, As Chief Medical Officer
French and Benelux stocks-Factors to watch on July 16
Brief: Medincell To Repay €20 Mln Of €40 Mln EIB Credit Facility Early
Europe Research Roundup: Atlas Copco, Lloyds, Poste Italiane
Medincell drops after 'lower-than-expected' FY revenue
French and Benelux stocks-Factors to watch on June 17
Brief: Medincell FY Total Revenue At Eur 24.3 Mln
France's MedinCell FY revenue drops on lower milestone income
Brief: Medincell Q1 2026 U.S. Net Sales Reached $63 Million
French and Benelux stocks-Factors to watch on March 27
Brief: Medincell Says EIB Waives Right To Cash Settlement Of Warrants
Brief: Medincell Completes EUR 48 Mln Private Placement
Brief: Medincell Launches A Private Placement For International Institutional Investors
Europe Research Roundup: CSG, Hochschild, Vestas
Brief: Medincell Says Uzedy Net Sales Increased 63% To $191 Million In 2025